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Abstract
Background: Hypotensive epidural anaesthesia (HEA) combines a high epidural anaesthesia,
performing a sympathetic blockade, with low-dose iv-infusion of epinephrine to stabilize circulation
in the conscious patient. Mean artery blood pressure is reduced to 45–50 mmHg and hereby a
reduced blood loss. In this study we have combined HEA with preoperative acute normovolaemic
hemodilution (ANH) in attempt to further reduce the blood loss and need for blood transfusion in
total knee arthroplasty surgery (TKR).
Methods: Twenty-eight patients scheduled for TKR are randomised to ANH or no hemodilution
(non-ANH). Both groups are anaesthetized with HEA. ANH is established with predonation of 20
% of the total blood volume, and replacement with equal volume of HAES 6 %. Blood re-transfusion
is completed within 6 h.
Results: A mean of 877 ml blood was predonated (19.7 % of the total blood volume). Blood loss
was, except from the intraoperative loss, significantly higher in ANH group. The total loss was 1306
mL (ANH) vs. 1026 mL (non-ANH), p < 0.05. Except from the first hour postoperatively,
hematocrit was identical in between groups postoperatively. The amount of blood transfusion was
identical 386 ml (ANH) vs. 343 ml (non-ANH) (ns). 50 % went through surgery without receiving
blood (ANH) vs. 58 % (non-ANH). No renal, neurological or cardiopulmonary complications were
registered.
Conclusions: These data suggest no benefits in combining HEA and ANH in TKR surgery.
Probably because of the reduced viscosity of the blood after ANH, there is an increased
postoperative blood loss. The need for homologous blood transfusion was identical.
Background
The risks associated with banked homologous blood
products are well known. These risks include among oth-
ers: ABO incompatibilities, viral or bacterial infections,
and immunosuppression [1]. Immunomodulation may
have long lasting effects on the patient who has received a
single unit of homologous blood, and may alter the im-
mune response in a way that may render the recipient vul-
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nerable to infection [2]. Several techniques for
management of surgical patients without homologous
blood transfusion are available. Acute normovolaemic he-
modilution (ANH) is the simultaneous exchange of
whole blood with an identical volume of an iso-oncotic
colloid. The resulting dilutional anaemia is compensated
for by an increase in cardiac output and enhanced arterial
oxygen extraction. Although bleeding during surgery re-
mains essentially unchanged, blood lost during the surgi-
cal procedure contains fewer red cells because the
patient's blood has been diluted. At the conclusion of sur-
gery or when needed, donated blood may be returned to
the patient [3]. ANH is found to be effective in surgical
cases with a high-expected blood loss [4]. The concept of
decreasing the arterial blood pressure to hypotensive lev-
els during anaesthesia and surgery has been used for dec-
ades in attempt to reduce intraoperative blood loss and to
improve conditions in the surgical field. A mean arterial
blood pressure (MAP) of 55–60 mmHg has been regarded
as the lowest safe level in young healthy patients, one of
the reasons being that this range represents the lowest
MAP at which auto regulation of the cerebral blood flow
is still active.
Sharrock introduced the hypotensive epidural anaesthesia
(HEA) in 1989 [5]. Epidural anaesthesia was used to es-
tablish a sympathetic blockade, causing a hypotensive
state. Low dose of epinephrine was infused to maintain
and stabilize cardiac output and heart rate. During HEA, a
MAP of 45–50 mmHg was allowed since the cerebral con-
dition could be monitored through the patient's ability to
communicate, as only slight sedation was used. HEA is a
safe technique with a low complication – and mortality
rate, even in patients with left ventricular dysfunction [6–
8]. This method reduces blood loss and need for transfu-
sions significantly in hip arthroplasty surgery [9]. We have
in a previous paper demonstrated a reduced perioperative
blood loss at 47 % in knee arthroplasty surgery (TKR) dur-
ing HEA [10].
The aim of this study was to evaluate the potential bene-
fits of a reduced need for homologous blood transfusion
by combining HEA and ANH in TKR surgery.
Methods
The study was approved by the regional scientific ethics
committee and corresponds with the Helsinki II declara-
tion. In all patients written informed consent was ob-
tained.
Twenty-eight patients scheduled for primary cemented
TKR surgery were included in the study period. Exclusion
criteria were: Patients underage (<18 years), hematocrit <
0.30, recent myocardial infarction (<6 months), unstable
angina, diagnosed and clinical symptomatic aortic- or mi-
tral valve stenosis (>30 mmHg), previous stroke, unmed-
icated hypertension and treatment with beta-antagonists
or anticoagulants. No patient was medicated with sali-
cylate or nonsteroidal anti-inflammatory drugs in the two
weeks prior to surgery.
On the day of surgery patients were consecutive and
blindly randomised to HEA with or without ANH using
computerised randomisation to two treatments (Med-
Stat®).
ANH was performed by drawing 20 % of the total blood
volume through a venous cannula immediately before an-
aesthesia. This volume was simultaneously replaced with
an equal volume of Hydroxy Ethyl Starch 6 % (HAES 6
%). The following formula was used:
Total blood volume = body weight (kg) ×  60 mL per kg.
The donated volume of blood was collected in transfusion
bags together with a stabilizer. Until re-transfusion in the
recovery room, the blood was storaged in a cooler box. Re-
transfusion was terminated within 6 hours. Both groups
were anaesthetized with the hypotensive epidural anaes-
thesia technique.
HEA
To establish the sympathetic blockade, epidural anaesthe-
sia was performed at the Th12-L1/L1-L2 interspace with
ropivacaine 1%, 25–35 ml to achieve analgesia at Th1-2
dermatome. For epidural infusion, ropivacaine 1% 6–8
ml/h was used until end of surgery. The infused dose var-
ied according to the patient's age, height and weight. The
arterial pressure decreased progressively over 10 minutes
after the epidural bolus injection to a MAP of 45–50 mm-
Hg. In case of insufficient decrease in blood pressure, bo-
lus ropivacaine 5 ml epidurally was used. Infusion of
epinephrine 0.01–0.07 µg/kg/min was started immediate-
ly after insertion of the central vein catheter; in order to
prime the catheter before the sympathetic blockade was
established. During surgery sedation with propofol was
adjusted to a level where communication was possible.
Intraoperative infused fluid volume was in both groups
isotonic saline 5 mL/kg/h as basic need and Isotonic sa-
line three times the amount of blood loss as substitution
for intraoperative blood loss. Oxygen was delivered at 3 l/
min on a nasal catheter. All patients were kept warm, us-
ing a Bair-hugger. No knee tourniquet was used.
Monitoring: 5-lead ECG, pulse oximetry, respiratory rate,
end-tidal CO2, radial- and central venous pressures. All
data were continuously recorded on a computer, using the
Datex Collect (software (Datex, Denmark).BMC Anesthesiology 2002, 2 http://www.biomedcentral.com/1471-2253/2/1
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Infusion of epinephrine was continued postoperatively
until MAP reached 75 mmHg, hereafter epinephrine was
reduced gradually until removal. In both groups, the in-
traoperative blood loss was determined by measurement
of the volume in the suction apparatus, and by weighing
of towels. The postoperative blood loss was determined
by measuring the drainage for 48 hours after operation.
Drains were removed after 48 hours.
Postoperative analgesia was performed as patient control-
led epidural analgesia using ropivacaine 0.2 % and mor-
phine 0.05 mg/ml for three days, according to our normal
routine. The epidural catheter was removed on the third
postoperative day. Hereafter the patients were treated
orally with morphine and acetaminophen. Fragmin® was
given as thrombo-prophylaxis. All patients used a contin-
uous passive knee motion apparatus the first two postop-
erative days.
The patients were anaesthetized by one of the three anaes-
thesiologist authors and operated by two surgeons. De-
mographics, hematocrit pre- and post ANH, at arrival at
recovery room, and at 1., 2., 3., and 5. postoperative day
were recorded. Intra- and postoperative fluid- and blood
transfusions were also registered. Blood transfusion was
indicated when the hematocrit value was below 28 %.
Statistics
After passing through the exclusion criteria patients were
consecutive and blindly randomised to HEA with or with-
out ANH using computerised random numbers for 2
treatments (MedStat®). The result of the randomisation
was known immediately before anaesthesia.
Data are presented as means (SD) or means (range). Com-
parison between groups was performed with a Student's t-
test. For ASA-score a Mann Whitney's test was used. Chi-
test was applied on gender and the fraction of transfused
patients in the two groups. A p < 0.05 was chosen as sig-
nificance level.
The sample size of this study was determined by an ex-
pected effect of ANH on blood transfusion rate of 50 %
(MIREDIF). α  = 5 %, β  = 10 %, SD = 400
n1 = n2 = 2(t2( + tβ )2SD2/MIREDIF2
Power = (1-β ) = 1-0.10 = 0.90
This calculation resulted in 13 patients in each group. We
decided to enrol 14 in each group.
Results
In all 33 patients were screened to enter this study. Three
patients were excluded because of treatment with beta-an-
tagonists and 2 patients because of previous stroke.
Twenty-eight patients, 14 ANH and 14 non-ANH were en-
rolled in the study. Patient characteristics and preopera-
tive blood measurements are shown in Table 1. Except
from the preoperative mean artery blood pressure (meas-
ured before blood donation) there was no significant dif-
ference in between groups. Intraoperative values are
shown in Table 2. The ANH group was given ropivacaine
1 %, mean 288 ± 32 mg and non-ANH ropivacaine 1 %,
297 ± 22 mg (ns). The intraoperative mean artery blood
pressure was identical between groups. MAP demonstrat-
ed a reduction of 53.4 % (ANH) and of 58.4 % (non-
NAH), compared to preoperative blood pressure (ns).
Postoperatively in the recovery room, MAP was below 75
mmHg for 38 min ± 40 (ANH) vs. 52 min ± 77 (non-
Table 1: Demographics and preoperative measurements of the 
patients.
ANH Non-ANH P
n1 4 1 4
Sex, F/M 10/4 11/3 1.00
Age, yr 75.8 (6.4) 70.1 (9.6) 0.08
Weight, kg 75 (11.5) 76 (13.2) 0.81
Height, cm 166 (8) 166 (10) 0.98
ASA (median (range)) 2 (1–2) 2 (1–2) 0.75
Mean arterial blood pressure, 
mmHg
103 (12) 118 (19) 0.02*
Total blood volume, mL 4471 (809) 4446 (736) 0.93
ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolae-
mic hemodilution; Mean (SD) * significance
Table 2: Perioperative values for the patients.
ANH 14 Non-ANH 14 P
Mean arterial blood pressure, 
mmHg
47.9 (1.8) 49.0 (3.6) 0.31
Central vein pressure, mmHg 4.5 (2) 6.1 (4) 0.21
Duration of surgery, min 93 (13) 100 (20) 0.26
Duration of anaesthesia, min 182 (15) 193 (23) 0.16
Duration of hypotension, min 102 (20) 110 (22) 0.34
Core temperature after surgery, 
C
36.5 (0.4) 36.7 (0.7) 0.20
Postoperative ICU-time, hrs 6.8 (1.2) 7.1 (0.8) 0.36
ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolae-
mic hemodilution; Mean (SD) * significanceBMC Anesthesiology 2002, 2 http://www.biomedcentral.com/1471-2253/2/1
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ANH) (p = 0.56). Time used for anaesthesia (from patient
enters the operating theatre to entering the recovery
room) and duration of surgery was identical between
groups. Core temperature on admission to the recovery
room was also without a significant difference.
The preoperative donated blood volume was mean 877
mL ± 175, or 19.7 % of the total blood volume. All blood
was retransfused to ANH patients in the recovery room.
Perioperative blood loss and substitution are shown in Ta-
ble 3. At almost all registrations there was a reduced blood
loss in non-ANH group. Colloid substitution was in ANH
group 679 mL and blood transfusion 386 mL, without in-
cluding the infusion of HAES used in the ANH procedure
and the predonated amount of blood. Fifty percent in the
ANH group received homologous blood transfusion dur-
ing the hospital stay (771 mL pr. patient transfused) vs. 42
% in non-ANH group (800 mL pr. patient transfused)
(ns). Numbers of units packed red cells are shown in Ta-
ble 4. No patients received blood components other than
erythrocytes.
The perioperative blood analysis demonstrated, except
from hematocrit at start and conclusion of surgery, no dif-
ferences (Table 5).
There was no difference in time spent in hospital between
the groups. At the 7'Th postoperative day all patients in
this study were transferred to a hotel department for fur-
ther mobilisation. During the hospital stay we did not ob-
serve any cases of renal failure according to the Creatinine
measurements. All patients were discharged from the hos-
pital alive.
Discussion
In both groups there was a remarkable low total blood
loss, due to the anaesthetic technique used (HEA). The
blood loss was, especially the non-ANH group, in a range
identical with the result of our previous study comparing
HEA with normotensive regional anaesthesia in TKR sur-
gery [10]. ANH failed in the present study to demonstrate
a reduced need for blood transfusion with homologous
blood products during TKR surgery in HEA anaesthesia.
We here use a moderate hemodilution (20 % of total
blood volume) to a hematocrit near 30% agreeing with
the recommendations for patients at this age [11]. Despite
of this 50% in the ANH group received homologous
Table 3: Blood loss and substitution for the patients.
ANH 14 Non-ANH 14 P
Blood loss intraoperative, mL 131 (78) 111 (56) 0.45
Blood loss 1. postop. Hour, mL 295 (129) 204 (77) 0.03*
Blood loss 2. postop. Hour, mL 192 (98) 118 (72) 0.03*
Blood loss 3. postop. Hour, mL 132 (85) 111 (61) 0.47
Blood loss 24. postop hours, mL 1057 (292) 836 (280) 0.05*
Blood loss 2. postop day, mL 109 (78) 83 (67) 0.36
Total blood loss, mL 1306 (300) 1026 (294) 0.02*
Homologous blood transfusion 
(PRC), mL
386 (720) 343 (454) 0.85
Crystalloid first 24 hours, mL 3229 (582) 3312 (731) 0.75
Colloid first 24 hours, mL 679 (575) 377 (361) 0.12
Donated amount of blood, mL 877 (175)
ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolae-
mic hemodilution; Mean (SD) * significance
Table 4: Patients receiving blood substitution (units of packed red 
cells).
ANH 14 Non-ANH 14 P
Zero 7 8
1 unit 4 0
2 Units 1 4
3 Units 1 0
>3 Units 1 2
Average transfused, mL 386 343 0.85
ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolae-
mic hemodilution
Table 5: Perioperative blood measurements.
ANH 14 Non-ANH 14 P
Hematocrit preoperative, % 38.7 (3) 38.1 (5) 0.71
Hematocrit at start of surgery, % 30.4 (5) 38.1 (5) 0.001
*
Hematocrit 1. hour postop, % 28.7 (3) 32 (4) 0.04*
Hematocrit 1. postop day, % 29.8 (3) 29.9 (4) 0.91
Hematocrit 2. postop day, % 30.7 (3) 29.9 (4) 0.63
Hematocrit 3. postop day, % 30.4 (3) 28.8 (2) 0.14
Hematocrit 5. postop day, % 29.4 (3) 30.3 (4) 0.53
Platelet count preoperative, 106/l 257 (72) 265 (63) 0.35
Platelet count 1. postop day, 106/
l
190 (60) 185 (42) 0.81
Platelet count 5. postop day, 106/
l
322 (85) 337 (77) 0.38
APTT preoperative, sec 32 (3) 30 (3) 0.16
Creatinine preoperative, mol/L 83 (21) 85 (23) 0.79
Creatinine 1. postop.day, mol/L 82 (20) 80 (17) 0.58
Creatinine 5. postop day, mol/L 80 (22) 74 (13) 0.39
ANH: Acute normovolaemic hemodilution; non-ANH: No acute normovolae-
mic hemodilution; Mean (SD) * significanceBMC Anesthesiology 2002, 2 http://www.biomedcentral.com/1471-2253/2/1
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blood. In a previous ANH study without the use of HEA
anaesthesia, 45 % of TKR patients received homologous
blood [12]. A case study analysis of patients who had un-
dergone moderate ANH (15 % of patients blood volume)
estimated that only 0.5 unit of blood is "saved" [13].
Mathematical models concur that savings are small unless
profound hemodilution is accompanied by large blood
loss (> 2 L) [14]. Another study postulates that the safety
and efficacy of more extensive hemodilution is controver-
sial because it is not possible for all patients and may pro-
vide only little additional blood conservation [15].
At almost all registrations the ANH group demonstrated
an increased postoperative blood loss compared to the
non-ANH group. Dilution of the blood after ANH is the
most reasonable explanation to this. TKR surgery is
known to be associated with extensive postoperative
blood loss, probably because of difficulties in performing
postoperative compression and haemostasis of the tissue
in the knee [10]. This fact combined with the reduced vis-
cosity of the blood could increase the postoperative blood
loss. We did not register any difference in time spent in
surgery or postoperative hypotension that could explain
differences in the blood loss. In a previous study mild hy-
pothermia was found to be correlated to a significantly in-
creased blood loss in hip arthroplasty surgery [16]. We did
not register differences in postoperative core temperature.
Another possible explanation for the difference in blood
loss could be alternation of the coagulation system be-
cause of the hemodilution. ANH is found to cause a slight
coagulopathy including a decrease in platelet count, pro-
thrombin time, fibrinogen, AT-III and plasminogen. Fur-
thermore APTT is increased. The combination of ANH
and prostaglandin E1 induced hypotension to 55 mmHg
did not alter the coagulation system any further [17]. Pre-
and postoperative platelet count and APTT were in our
study without significant differences. The registered differ-
ence in the mean age between the groups must be without
significant influence on the perioperative blood loss. We
found no complications related to the brain or the heart
during the hospital stay. In a recently published work,
HEA demonstrates identical rates of cardiac and throm-
boembolic complications in elderly patients compared to
normotensive epidural anaesthesia. Furthermore, there
were no differences in early or long-term cognitive dys-
function [18]. None of the patients died in the periopera-
tive period, in agreement with the very low mortality
described by Sharrock [7].
Conclusions
HEA is found to reduce the perioperative blood loss and
the need for transfusion compared to conventional anaes-
thesia [9,10], but the combination of HEA and ANH
seems in this study to be without any further benefits re-
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